Skip to main content
Erschienen in: Breast Cancer Research 3/2001

01.06.2001 | Commentary

The complexities of breast cancer desmoplasia

verfasst von: Rosemary A Walker

Erschienen in: Breast Cancer Research | Ausgabe 3/2001

Einloggen, um Zugang zu erhalten

Abstract

The stromal, or 'desmoplastic', responses seen histologically in primary breast carcinomas can vary from being predominantly cellular (fibroblasts/myofibroblasts) with little collagen to being a dense acellular tissue. The mechanisms underlying the stromal response are complex; paracrine activation of myofibroblasts by growth factors is important but the contribution of cytokines/chemokines should not be ignored. A recent xenograft study has proposed that platelet-derived growth factor (PDGF) is the initiator of the desmoplastic response, but this has not been confirmed by (limited) analyses in vivo. Further studies are required to elaborate the mechanisms of the desmoplastic response, to determine its role in breast cancer progression and whether it is the same for all carcinomas.
Literatur
1.
Zurück zum Zitat Jackson JG, Orr JW: The ducts of carcinomatous breasts with particular reference to connective tissue changes. J Pathol Bacteriol. 1957, 74: 265-273.CrossRef Jackson JG, Orr JW: The ducts of carcinomatous breasts with particular reference to connective tissue changes. J Pathol Bacteriol. 1957, 74: 265-273.CrossRef
2.
Zurück zum Zitat Barsky SH, Rao CN, Grotendorst GR, Liotta LA: Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol. 1982, 108: 276-283.PubMedPubMedCentral Barsky SH, Rao CN, Grotendorst GR, Liotta LA: Increased content of type V collagen in desmoplasia of human breast carcinoma. Am J Pathol. 1982, 108: 276-283.PubMedPubMedCentral
3.
Zurück zum Zitat Lagacé R, Grimaud J-A, Schürch , Seemayer TA: Myofibroblastic stromal reaction in carcinoma of the breast: variations of collagenous matrix and structural glycoproteins. Virchows Arch. 1985, 408: 49-59.CrossRef Lagacé R, Grimaud J-A, Schürch , Seemayer TA: Myofibroblastic stromal reaction in carcinoma of the breast: variations of collagenous matrix and structural glycoproteins. Virchows Arch. 1985, 408: 49-59.CrossRef
4.
Zurück zum Zitat Dvorak HF, Dickersin GR, Dvorak AM, Manseau EJ, Pyne K: Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and Infarction. J Natl Cancer Inst. 1981, 67: 335-345.PubMed Dvorak HF, Dickersin GR, Dvorak AM, Manseau EJ, Pyne K: Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and Infarction. J Natl Cancer Inst. 1981, 67: 335-345.PubMed
5.
Zurück zum Zitat Dvorak HF: Tumours: wounds that do not heal. Similarities between tumour stroma generation and healing. N Engl J Med. 1986, 315: 1650-1659.CrossRefPubMed Dvorak HF: Tumours: wounds that do not heal. Similarities between tumour stroma generation and healing. N Engl J Med. 1986, 315: 1650-1659.CrossRefPubMed
6.
Zurück zum Zitat Peres R, Betsholtz C, Westermark B, Heldin C-H: Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res. 1987, 47: 3425-3429.PubMed Peres R, Betsholtz C, Westermark B, Heldin C-H: Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res. 1987, 47: 3425-3429.PubMed
7.
Zurück zum Zitat Ethier SP: Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995, 87: 964-973.CrossRefPubMed Ethier SP: Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995, 87: 964-973.CrossRefPubMed
8.
Zurück zum Zitat Horgan K, Jones DL, Mansel RE: Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br J Surg. 1987, 74: 227-229.CrossRefPubMed Horgan K, Jones DL, Mansel RE: Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br J Surg. 1987, 74: 227-229.CrossRefPubMed
9.
Zurück zum Zitat Ronnov-Jessin L, Petersen OW: Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Lab Invest. 1993, 68: 696-707. Ronnov-Jessin L, Petersen OW: Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Lab Invest. 1993, 68: 696-707.
10.
Zurück zum Zitat Ellis MJC, Singer C, Hornby A, Rasmussen A, Cullen KJ: Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat. 1994, 31: 249-261.CrossRefPubMed Ellis MJC, Singer C, Hornby A, Rasmussen A, Cullen KJ: Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat. 1994, 31: 249-261.CrossRefPubMed
11.
Zurück zum Zitat Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME: Synthesis and secretion of platelet derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA. 1987, 84: 5763-5767.CrossRefPubMedPubMedCentral Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME: Synthesis and secretion of platelet derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA. 1987, 84: 5763-5767.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Povlsen CO: Heterotransplants of human tumours in nude mice. Antibiot Chemother. 1980, 28: 15-20.CrossRefPubMed Povlsen CO: Heterotransplants of human tumours in nude mice. Antibiot Chemother. 1980, 28: 15-20.CrossRefPubMed
13.
Zurück zum Zitat Shao Z-M, Nguyen M, Barsky SH: Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 2000, 19: 4337-4345. 10.1038/sj/onc/1203785.CrossRefPubMed Shao Z-M, Nguyen M, Barsky SH: Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 2000, 19: 4337-4345. 10.1038/sj/onc/1203785.CrossRefPubMed
14.
Zurück zum Zitat Dickson RB, Kasid A, Huff KC, Bates SE, Knabbe C, Bronzert D, Gelmann EP, Lipmann ME: Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or vH-ras oncogene. Proc Natl Acad Sci USA. 1987, 84: 837-841.CrossRefPubMedPubMedCentral Dickson RB, Kasid A, Huff KC, Bates SE, Knabbe C, Bronzert D, Gelmann EP, Lipmann ME: Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or vH-ras oncogene. Proc Natl Acad Sci USA. 1987, 84: 837-841.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Basset P, Bellocq JP, Woy C, Stoll I, Huton P, Limacher JM, Podhajcer DL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specificity expressed in stromal cells of breast carcinomas. Nature. 1990, 348: 699-704. 10.1038/348699a0.CrossRefPubMed Basset P, Bellocq JP, Woy C, Stoll I, Huton P, Limacher JM, Podhajcer DL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specificity expressed in stromal cells of breast carcinomas. Nature. 1990, 348: 699-704. 10.1038/348699a0.CrossRefPubMed
16.
Zurück zum Zitat Tomlinson J, Barsky SH, Nelson S, Singer S, Pezeshki B, Lee MC, Eilber F, Nguyen M: Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res. 1999, 5: 3516-3522.PubMed Tomlinson J, Barsky SH, Nelson S, Singer S, Pezeshki B, Lee MC, Eilber F, Nguyen M: Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res. 1999, 5: 3516-3522.PubMed
17.
Zurück zum Zitat Rasmussen BB, Rose C, Thorpe SM, Hou-Jenson K, Daehnfeldt JL, Palshof T: Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch. 1981, 390: 347-351.CrossRef Rasmussen BB, Rose C, Thorpe SM, Hou-Jenson K, Daehnfeldt JL, Palshof T: Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch. 1981, 390: 347-351.CrossRef
18.
Zurück zum Zitat De Jong JS, van Diest PJ, van der Valk, Baak JPA: Expression of growth factors, growth-inhibiting factors and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops. J Pathol. 1998, 184: 44-52. 10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.3.CO;2-8.CrossRefPubMed De Jong JS, van Diest PJ, van der Valk, Baak JPA: Expression of growth factors, growth-inhibiting factors and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops. J Pathol. 1998, 184: 44-52. 10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.3.CO;2-8.CrossRefPubMed
19.
Zurück zum Zitat Walker RA, Dearing SJ, Gallacher B: Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinomas. Br J Cancer. 1994, 69: 1160-1165.CrossRefPubMedPubMedCentral Walker RA, Dearing SJ, Gallacher B: Relationship of transforming growth factor β1 to extracellular matrix and stromal infiltrates in invasive breast carcinomas. Br J Cancer. 1994, 69: 1160-1165.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Walker RA, Dearing SJ: Transforming growth factor β1 expression in in-situ and invasive breast cancers. Eur J Cancer. 1992, 28: 641-644.CrossRefPubMed Walker RA, Dearing SJ: Transforming growth factor β1 expression in in-situ and invasive breast cancers. Eur J Cancer. 1992, 28: 641-644.CrossRefPubMed
21.
Zurück zum Zitat Ronnov-Jenson L, Petersen OW, Bissel M: Cellular changes involved in the conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996, 76: 69-125. Ronnov-Jenson L, Petersen OW, Bissel M: Cellular changes involved in the conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996, 76: 69-125.
22.
Zurück zum Zitat Jones JL, Glynn P, Walker RA: Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1-MMP in primary breast carcinomas. J Pathol. 1999, 189: 161-168. 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2.CrossRefPubMed Jones JL, Glynn P, Walker RA: Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1-MMP in primary breast carcinomas. J Pathol. 1999, 189: 161-168. 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2.CrossRefPubMed
23.
Zurück zum Zitat De Jong JS, van Diest PJ, van der Valk P, Baak JPA: Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II. Correlations with proliferation and angiogenesis. J Pathol. 1998, 184: 53-57. 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7.CrossRefPubMed De Jong JS, van Diest PJ, van der Valk P, Baak JPA: Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II. Correlations with proliferation and angiogenesis. J Pathol. 1998, 184: 53-57. 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7.CrossRefPubMed
24.
Zurück zum Zitat Devalaraja MN, Richmond A: Multiple chemotactic factors: fine control or redundancy?. Trends Pharmacol Sci. 1999, 20: 151-156. 10.1016/S0165-6147(99)01342-5.CrossRefPubMed Devalaraja MN, Richmond A: Multiple chemotactic factors: fine control or redundancy?. Trends Pharmacol Sci. 1999, 20: 151-156. 10.1016/S0165-6147(99)01342-5.CrossRefPubMed
25.
Zurück zum Zitat Steffen CL, Ball-Mirth DK, Harding PA, Bhattacharyya N, Pillai S, Brigstock DR: Characterization of cell associated and soluble forms of connective tissue growth factor produced by fibroblast cells in vitro. Growth Factors. 1998, 15: 199-123.CrossRefPubMed Steffen CL, Ball-Mirth DK, Harding PA, Bhattacharyya N, Pillai S, Brigstock DR: Characterization of cell associated and soluble forms of connective tissue growth factor produced by fibroblast cells in vitro. Growth Factors. 1998, 15: 199-123.CrossRefPubMed
Metadaten
Titel
The complexities of breast cancer desmoplasia
verfasst von
Rosemary A Walker
Publikationsdatum
01.06.2001
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 3/2001
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr287

Weitere Artikel der Ausgabe 3/2001

Breast Cancer Research 3/2001 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.